INS and type 2 diabetes mellitus: Methods: Using Taiwan’s National Health Insurance Research Database (2008–2021), we conducted a retrospective cohort study and identified 6779 propensity score-matched pairs of insulin-treated patients with T2D who initiated either GLP-1 RAs or dipeptidyl peptidase-4 (DPP-4) inhibitors.